Skip to content

NMN for Male Fertility Decline and Andropause: What the Evidence Actually Shows

Category: reproductive | ICD-10: N50.89 | Evidence tier: no-evidence

What is Male Fertility Decline and Andropause?

Male fertility declines more slowly than female, but sperm quality drops with age. Andropause refers to the gradual fall in testosterone with associated fatigue, low libido and mood change.

NMN relevance: the published evidence

Irie 2020 in middle-aged Japanese men was a safety and pharmacokinetic study, not a fertility or testosterone trial. No NMN RCT has measured sperm parameters or testosterone as primary outcomes. Established treatments include testosterone replacement when clinically indicated.

Questions to ask before supplementing

No dose validated for male fertility or andropause.

Contraindications and red flags

Low testosterone needs lab confirmation; do not self-treat with supplements.

Bottom line for Malaysian patients

NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have male fertility decline and andropause, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.

Related conditions

Cited references